The Discounted Cash Flow (DCF) valuation of Haemonetics Corp (HAE) is 105.54 USD. With the latest stock price at 70.31 USD, the upside of Haemonetics Corp based on DCF is 50.1%.
Based on the latest price of 70.31 USD and our DCF valuation, Haemonetics Corp (HAE) is a buy. buying HAE stocks now will result in a potential gain of 50.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.2% | 7.3% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 67.31 - 216.81 | 105.54 |
| Upside | -4.3% - 208.4% | 50.1% |